This webinar will explore the role of novel therapeutic approaches for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) beyond traditional treatment options. Participants will gain insight into how these emerging therapies may be positioned to optimize outcomes in patients with refractory disease. The session will also highlight ongoing research into their safety and efficacy, as well as advances in emerging biomarkers for assessing disease activity and guiding more informed therapeutic decision-making:
Date: 3 March 2026
Time: 16:00-17:00 (CET)
Chair: Thomas Harbo
Speakers: Pietro Doneddu, Roberto Bellanti, Louis Querol
Registration is open to everyone with a MyEAN account. EAN membership is not required to attend the webinar. If you do not already have a myEAN account, you can create one here: https://my.ean.org.
For more information and to register, please click the LINK
This webinar is supported by an independent educational grant from argenx.
___________________________________
